AGP Executive Report
Last update: 11 hours agoFDA Oversight: The American Medical Association is urging the FDA to apply drug-level safety and efficacy standards to botanical products, including cannabis, as potent oils, gummies and other products spread. Cannabis M&A: Organigram beat Curaleaf with a C$561 million offer for Aurora Cannabis, at C$7.80 a share—a 32.4% premium—with the deal expected to close in January 2027. Federal Hemp Rules: A December deadline for new federal hemp definitions could make many hemp-derived products illegal, raising alarm among CBD businesses and consumers. Medical Cannabis: The DEA has begun granting federal registrations to more than 900 medical marijuana dispensaries, a move that could affect compliance and access to tax relief.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
